Literature DB >> 11015811

The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study.

G Ende1, D F Braus, S Walter, W Weber-Fahr, F A Henn.   

Abstract

BACKGROUND: We monitored the effect of electroconvulsive therapy (ECT) on the nuclear magnetic resonance-detectable metabolites N-acetylaspartate, creatine and phosphocreatine, and choline-containing compounds in the hippocampus by means of hydrogen 1 magnetic resonance spectroscopic imaging. We hypothesized that if ECT-induced memory deterioration was associated with neuronal loss in the hippocampus, the N-acetylaspartate signal would decrease after ECT and any increased membrane turnover would result in an increase in the signal from choline-containing compounds.
METHODS: Seventeen patients received complete courses of ECT, during which repeated proton magnetic resonance spectroscopic imaging studies of the hippocampal region were performed. Individual changes during the course of ECT were compared with values obtained in 24 healthy control subjects and 6 patients remitted from major depression without ECT.
RESULTS: No changes in the hippocampal N-acetylaspartate signals were detected after ECT. A significant mean increase of 16% of the signal from choline-containing compounds after 5 or more ECT treatments was observed. Despite the mostly unilateral ECT application (14 of 17 patients), the increase in the choline-containing compound signal was observed bilaterally. Lactate or elevated lipid signals were not detected. All patients showed clinical amelioration of depression after ECT.
CONCLUSIONS: Electroconvulsive therapy is not likely to induce hippocampal atrophy or cell death, which would be reflected by a decrease in the N-acetylaspartate signal. Compared with an age-matched control group, the choline-containing compounds signal in patients with a major depressive episode was significantly lower than normal, before ECT and normalized during ECT.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015811     DOI: 10.1001/archpsyc.57.10.937

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  36 in total

Review 1.  [Value of diagnostic imaging in evaluation of electroconvulsive therapy].

Authors:  T Frodl; E M Meisenzahl; H-J Möller
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

2.  Rational electroconvulsive therapy electrode placement.

Authors:  Conrad M Swartz; Alexander I Nelson
Journal:  Psychiatry (Edgmont)       Date:  2005-07

3.  Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia.

Authors:  Joshua Chiappelli; Laura M Rowland; S Andrea Wijtenburg; Florian Muellerklein; Malle Tagamets; Robert P McMahon; Frank Gaston; Peter Kochunov; L Elliot Hong
Journal:  Neuropsychopharmacology       Date:  2015-02-27       Impact factor: 7.853

Review 4.  [Adverse cognitive effects and ECT].

Authors:  Michael Prapotnik; Roger Pycha; Csaba Nemes; Peter König; Armand Hausmann; Andreas Conca
Journal:  Wien Med Wochenschr       Date:  2006-04

5.  Psychotherapy and antidepressant treatment of depression: evidence for similar neurobiological mechanisms.

Authors:  Fritz A Henn; Emmeline Edwards; David Anderson; Barbara Vollmayr
Journal:  World Psychiatry       Date:  2002-06       Impact factor: 49.548

Review 6.  Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.

Authors:  Stephen R Dager; Neva M Corrigan; Todd L Richards; Stefan Posse
Journal:  Top Magn Reson Imaging       Date:  2008-04

Review 7.  Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder.

Authors:  Robert W Van Boven; Greg S Harrington; David B Hackney; Andreas Ebel; Grant Gauger; J Douglas Bremner; Mark D'Esposito; John A Detre; E Mark Haacke; Clifford R Jack; William J Jagust; Denis Le Bihan; Chester A Mathis; Susanne Mueller; Pratik Mukherjee; Norbert Schuff; Anthony Chen; Michael W Weiner
Journal:  J Rehabil Res Dev       Date:  2009

Review 8.  Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders.

Authors:  Moonnoh R Lee; Aleksandar Denic; David J Hinton; Prasanna K Mishra; Doo-Sup Choi; Istvan Pirko; Moses Rodriguez; Slobodan I Macura
Journal:  Bioanalysis       Date:  2012-07       Impact factor: 2.681

9.  Subcortical and medial temporal MR-detectable metabolite abnormalities in unipolar major depression.

Authors:  Gabriele Ende; Traute Demirakca; Sigrid Walter; Tim Wokrina; Alexander Sartorius; Dirk Wildgruber; Fritz A Henn
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-02       Impact factor: 5.270

10.  Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden.

Authors:  Javier de Diego-Adeliño; Maria J Portella; Beatriz Gómez-Ansón; Olga López-Moruelo; Maria Serra-Blasco; Yolanda Vives; Dolors Puigdemont; Rosario Pérez-Egea; Enric Álvarez; Víctor Pérez
Journal:  J Psychiatry Neurosci       Date:  2013-03       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.